Monoclonal Anti-alpha-synuclein Antibodies For Preventing Tau Aggregation

Abstract

The invention relates to a novel use of monoclonal anti-alpha-synuclein antibodies. The antibodies can be used to prevent tau aggregation and thereby treating tauopathies such as Alzheimer's disease.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jul 30, 2019
  • Application: Dec 20, 2017
    US US 201715848999 A
  • Priority: Jan 5, 2017
    DK DK PA201700016 A
  • Priority: Dec 22, 2016
    DK DK PA201600782 A

Download Citation


Sign in to the Lens

Feedback